Watch Ticker

Biomea Fusion, Inc. Common Stock

Go to Biomea Fusion, Inc. Common Stock Website

$1.63

0.02 (1.20%)

Live

Previous Close

$1.61

Day Range

$1.56 - $1.65

Previous Day Range

$1.5606 - $1.6378

Market Cap

$89.5 million USD

Day Vol.

731693

Previous Day Vol.

596938

Currency

USD

Primary Exchange

Nasdaq

Biomea Fusion Inc is a clinical-stage diabetes and obesity medicines company focused on the discovery and development of oral covalent small-molecule drugs to treat patients with metabolic diseases. The company uses its proprietary FUSION System disc...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

N/A - Biomea Fusion Presents New Preclinical and Clinical Data on Icovamenib at the 85th Scientific Sessions of the American Diabetes Association (ADA)

Biomea Fusion presented new data on its investigational diabetes drug icovamenib at the ADA conference, highlighting its potential to enhance glycemic control and promote weight loss when combined with GLP-1 therapies, while preserving lean mass.

Related tickers: BMEA.

Read Full Article

N/A - Biomea Fusion Announces Pricing of Public Offering of Securities

Biomea Fusion, a clinical-stage diabetes and obesity company, announced the pricing of its underwritten public offering of common stock and warrants, expected to raise around $40 million.

Related tickers: BMEA.

Read Full Article

Trending Tickers

Please sign in to view